Pharmaceutical
Pipeline
OUR PIPELINE
Alongside our biotech partner, Galileo Biosystems, we've started to solidify our pharmeceutical pipeline to better understand how we can harness the properties found in therapeutic marine matter to better the lives of people around the world.
Programs
GB 499, 408
Aryl Hydrocarbon
Indications
Inflammatory
Phase
1. Discovery
2. Preclinical
3. Clinical
Next Milestone(s)
IND Enabling
Partners
Programs
SMD-5053
Novel Mechanism
Indications
Malaria
Phase
1. Discovery
2. Preclinical
3. Clinical
Next Milestone(s)
Proof of Mechanism
Partners
Programs
SMD-3218
cGAS Inhibitor
Indications
Type 1 Interferono pathies
Lupus / Vitiligo
Phase
1. Discovery
2. Preclinical
3. Clinical
Next Milestone(s)
Proof of Mechanism
Partners
Programs
SMD-5004
PKC Theta Agonist
Indications
Oncology
Phase
1. Discovery
2. Preclinical
3. Clinical
Next Milestone(s)
Proof of Mechanism
Partners
Programs
SMD-3265
PKC Theta Agonist
Indications
Oncology
Phase
1. Discovery
2. Preclinical
3. Clinical
Next Milestone(s)
Proof of Mechanism
Partners